Literature DB >> 16465603

Mean airway pressure and response to inhaled nitric oxide in neonatal and pediatric patients.

George M Hoffman1, Leif D Nelin.   

Abstract

Inhaled nitric oxide (iNO) can improve oxygenation and ventilation-perfusion (V/Q) matching by reduction of shunt (Qs/Qt) in patients with hypoxemic lung disease. Because the improvement in V/Q matching must occur by redistribution of pulmonary blood flow, and because high airway pressure (Paw) increases physiologic dead space (Vd/Vt), we hypothesized that high Paw may limit the improvement in V/Q matching during iNO treatment. iNO 0-50 ppm was administered during mechanical ventilation. Mechanical ventilator settings were at the discretion of the attending physician. Qs/Qt and Vd/Vt were derived from a tripartite lung model with correction for shunt-induced dead space. Data from 62 patients during 153 trials were analyzed for effects of Paw and iNO on Qs/Qt and Vd/Vt. Baseline Qs/Qt was slightly increased at Paw 16-23 cmH2O (p < 0.05), while Vd/Vt increased progressively with higher Paw (p < 0.002). Therapy with iNO significantly reduced Qs/Qt (p < 0.001) at all levels of mean Paw, reaching a maximum reduction at 16-23 cmH2O (p < 0.05), such that Qs/Qt during iNO treatment was similar at all levels of Paw. During iNO treatment, a reduction in Vd/Vt occurred only at Paw of 8-15 cmH2O (p < 0.05), and the positive relationship between Vd/Vt and Paw was maintained. These differential effects on Qs/Qt and Vd/Vt suggest that both high and low Paw may limit improvement in gas exchange with iNO. Analysis of gas exchange using this corrected tripartite lung model may help optimize ventilatory strategies during iNO therapy.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16465603     DOI: 10.1007/s00408-005-2555-2

Source DB:  PubMed          Journal:  Lung        ISSN: 0341-2040            Impact factor:   2.584


  30 in total

1.  Inhaled nitric oxide reduces the need for extracorporeal membrane oxygenation in infants with persistent pulmonary hypertension of the newborn.

Authors:  H Christou; L J Van Marter; D L Wessel; E N Allred; J W Kane; J E Thompson; A R Stark; S Kourembanas
Journal:  Crit Care Med       Date:  2000-11       Impact factor: 7.598

2.  Increasing tidal volumes and pulmonary overdistention adversely affect pulmonary vascular mechanics and cardiac output in a pediatric swine model.

Authors:  I M Cheifetz; D M Craig; G Quick; J J McGovern; M L Cannon; R M Ungerleider; P K Smith; J N Meliones
Journal:  Crit Care Med       Date:  1998-04       Impact factor: 7.598

3.  Randomized, controlled trial of low-dose inhaled nitric oxide in the treatment of term and near-term infants with respiratory failure and pulmonary hypertension.

Authors:  D N Cornfield; R C Maynard; R A deRegnier; S F Guiang; J E Barbato; C E Milla
Journal:  Pediatrics       Date:  1999-11       Impact factor: 7.124

4.  Nitric oxide and the lung.

Authors:  W M Zapol; S Rimar; N Gillis; M Marletta; C H Bosken
Journal:  Am J Respir Crit Care Med       Date:  1994-05       Impact factor: 21.405

5.  Effect of inhaled nitric oxide in combination with almitrine on ventilation-perfusion distributions in experimental lung injury.

Authors:  R Dembinski; M Max; F Lopez; R Kuhlen; M Sünner; R Rossaint
Journal:  Intensive Care Med       Date:  2000-02       Impact factor: 17.440

6.  An animal model of response and nonresponse to inhaled nitric oxide in endotoxin-induced lung injury.

Authors:  H Maurenbrecher; M Lamy; G Deby-Dupont; P Frascarolo; G Hedenstierna
Journal:  Chest       Date:  2001-08       Impact factor: 9.410

7.  Inhaled nitric oxide for avoidance of extracorporeal membrane oxygenation in the treatment of severe persistent pulmonary hypertension of the newborn.

Authors:  W Muller; W Kachel; P Lasch; V Varnholt; S A Konig
Journal:  Intensive Care Med       Date:  1996-01       Impact factor: 17.440

8.  The relationship between the arterial to end-tidal PCO2 difference and hemoglobin saturation in patients with congenital heart disease.

Authors:  R Fletcher
Journal:  Anesthesiology       Date:  1991-08       Impact factor: 7.892

9.  Interactive effects of high-frequency oscillatory ventilation and inhaled nitric oxide in acute hypoxemic respiratory failure in pediatrics.

Authors:  Emily L Dobyns; Nick G Anas; James D Fortenberry; Jayvant Deshpande; David N Cornfield; Robert C Tasker; Paul Liu; Patricia L Eells; Jeffery Griebel; John P Kinsella; Steven H Abman
Journal:  Crit Care Med       Date:  2002-11       Impact factor: 7.598

10.  In acute lung injury, inhaled nitric oxide improves ventilation-perfusion matching, pulmonary vascular mechanics, and transpulmonary vascular efficiency.

Authors:  N D Hillman; J N Meliones; D R Black; D M Craig; I M Cheifetz; P K Smith
Journal:  J Thorac Cardiovasc Surg       Date:  1995-09       Impact factor: 5.209

View more
  2 in total

Review 1.  Care of the critically ill neonate with hypoxemic respiratory failure and acute pulmonary hypertension: framework for practice based on consensus opinion of neonatal hemodynamics working group.

Authors:  Amish Jain; Regan E Giesinger; Shyamala Dakshinamurti; Yasser ElSayed; Robert P Jankov; Dany E Weisz; Satyan Lakshminrusimha; Souvik Mitra; Mjaye L Mazwi; Joseph Ting; Michael Narvey; Patrick J McNamara
Journal:  J Perinatol       Date:  2022-01-11       Impact factor: 3.225

2.  Inhaled nitric oxide for preterm premature rupture of membranes, oligohydramnios, and pulmonary hypoplasia.

Authors:  Valerie Y Chock; Krisa P Van Meurs; Susan R Hintz; Richard A Ehrenkranz; James A Lemons; Douglas E Kendrick; David K Stevenson
Journal:  Am J Perinatol       Date:  2008-12-09       Impact factor: 1.862

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.